Latest filing published 14 May 2024 for Quanterix Corp, €24k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Filings by Laurie J. Olson span 3 companies, the busiest being Pfizer Inc, Karuna Therapeutics, Inc. and Quanterix Corp. Over a trading history stretching from 13 September 2012 to 14 May 2024, the count stands at 94 filings.
Sales make up the whole of the open-market record (30 sales, €5.0M). Outside the open market, there are 41 share grants and 22 option exercises. 2024 to date brings no purchases and 4 sales.
Most recently, on 14 May 2024, the filings show an open-market sale worth €24k in Quanterix Corp. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
19 of 19 declarations